Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable and wide-ranging upper and lower-body improvements compared to placebo ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

Credit: Image generated by VentureBeat with FLUX-pro-1.1-ultra A quiet revolution is reshaping enterprise data engineering. Python developers are building production data pipelines in minutes using ...

Michael O'Connell, Chief Analytics Officer at Spotfire explores how the company uses data science, geospatial analytics and AI to boost the energy sector As industries continue to experience ...

They may be better known for stir-fries than supercomputing, but shiitake mushrooms have now been harnessed to function as living processors, storing and recalling data like a semiconductor chip but ...

The delayed release of the BLS report has led to fearmongering about the economy's ability to function. Leila Fadel, host of NPR's Up First, said on Friday that "businesses and policymakers are flying ...

At long last, the Health Connect app is expanding its "sharing data" function, allowing Android users to sync up their health information across multiple apps. The announcement came during Google's ...

NEW YORK, July 9 (Reuters) - TikTok is preparing to launch a standalone app for U.S. users that is expected to operate on a separate algorithm and data system from its global app, laying the ...

New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN) ...